SB1814 amends the Illinois Department of Public Health Powers and Duties Law to require the Department to take two public-health education actions. First, it creates a new section directing the Department to conduct educational activities for health care providers on amniotic fluid embolism, including its signs, symptoms, and management, and to post information about the condition on its website. The bill defines amniotic fluid embolism as a rare obstetric emergency involving amniotic fluid or fetal material entering the maternal bloodstream and causing severe cardiovascular, respiratory, and clotting complications.
Second, the bill adds a separate new section requiring the Department to adopt rules that compel local health departments to issue public announcements when a positive case of Rocky Mountain Spotted Fever is detected within their jurisdiction. The measure is framed as a public-awareness and provider-education bill rather than a regulatory or enforcement measure, and it takes effect immediately upon becoming law.
Impact
The bill expands the Department of Public Health’s statutory duties by adding two new public-information mandates: provider education and website publication regarding amniotic fluid embolism, and rulemaking for local public announcements about Rocky Mountain Spotted Fever cases. It does not create new penalties, licensing requirements, or benefit programs, but it does require administrative action by the Department and local health departments, and it affects public health communication practices in Illinois.
Sentiment
The available voting history shows strong bipartisan support and no recorded opposition: the bill passed the Senate 55-0, the House 105-0, and Senate concurrence 56-0. With no committee transcript provided, the overall sentiment appears broadly favorable and noncontroversial, consistent with a public-health education bill aimed at rare but serious medical conditions.
Contention
No notable contention is reflected in the provided record. The bill appears to have been treated as a straightforward public health measure, with unanimous votes in both chambers and concurrence without dissent. If any policy concern existed, it would likely have centered on the administrative burden of required announcements or the scope of Department rulemaking, but no such objections are documented here.